Public Profile

Searchlight Pharma Inc.

Searchlight Pharma Inc., headquartered in California, is a prominent player in the pharmaceutical industry, specialising in the development and commercialisation of innovative therapies. Founded in 2015, the company has rapidly established itself as a leader in the fields of rare diseases and specialty pharmaceuticals, focusing on areas with significant unmet medical needs. With a robust portfolio of unique products, Searchlight Pharma is dedicated to improving patient outcomes through targeted treatments. The company’s commitment to excellence is reflected in its strategic partnerships and successful product launches, which have garnered recognition within the healthcare community. As it continues to expand its operational reach across North America, Searchlight Pharma remains at the forefront of advancing healthcare solutions, solidifying its market position as a trusted provider of specialised therapies.

DitchCarbon Score

How does Searchlight Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Searchlight Pharma Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Searchlight Pharma Inc.'s reported carbon emissions

Searchlight Pharma Inc., headquartered in California, currently does not have available data on its carbon emissions, as no specific emissions figures have been reported. Consequently, there are no documented reduction targets or climate commitments outlined by the company at this time. In the absence of concrete emissions data, it is essential to note that many companies in the pharmaceutical industry are increasingly focusing on sustainability and climate action, often setting ambitious targets to reduce their carbon footprint. However, without specific information from Searchlight Pharma Inc., it is unclear what initiatives or commitments they may have in place regarding climate change and carbon emissions reduction.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Searchlight Pharma Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Searchlight Pharma Inc. is in CA, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Searchlight Pharma Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Valeo Pharma Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Bayer

DE
Chemicals nec
Updated about 23 hours ago

HLS Therapeutics Inc.

CA
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers